Literature DB >> 26481193

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.

A Nast1, P Gisondi2, A D Ormerod3, P Saiag4, C Smith5, P I Spuls6, P Arenberger7, H Bachelez8, J Barker9, E Dauden10, E M de Jong11, E Feist12, A Jacobs1, R Jobling13, L Kemény14, M Maccarone15, U Mrowietz16, K A Papp17, C Paul18, K Reich19, S Rosumeck1, T Talme20, H B Thio21, P van de Kerkhof22, R N Werner1, N Yawalkar23.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26481193     DOI： 10.1111/jdv.13354

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  82 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

Review 2.  "Inflammatory skin march" in atopic dermatitis and psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Inflamm Res       Date:  2017-06-15       Impact factor: 4.575

Review 3.  Remicade® (infliximab): 20 years of contributions to science and medicine.

Authors:  Richard Melsheimer; Anja Geldhof; Isabel Apaolaza; Thomas Schaible
Journal:  Biologics       Date:  2019-07-30

Review 4.  Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.

Authors:  Carolyn Jean Chua-Aguilera; Burkhard Möller; Nikhil Yawalkar
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

5.  The Presence of HLA-A Bw4-80I KIR Ligands Could Predict "Difficult-to-Treat" Psoriasis and Poor Response to Etanercept.

Authors:  M Guarene; A Pasi; V Bolcato; R Cananzi; A Piccolo; I Sbarsi; C Klersy; R Cacciatore; Valeria Brazzelli
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 6.  [Current guidelines in dermatology : A selection of clinically relevant recommendations].

Authors:  A Nast; S Rosumeck; R Erdmann; C Dressler; R N Werner
Journal:  Hautarzt       Date:  2016-05       Impact factor: 0.751

Review 7.  Multiple sclerosis: Dimethyl fumarate is coming of age.

Authors:  Mar Tintoré; Jaume Sastre-Garriga
Journal:  Nat Rev Neurol       Date:  2016-07-22       Impact factor: 42.937

Review 8.  Management of psoriasis patients with hepatitis B or hepatitis C virus infection.

Authors:  Claudio Bonifati; Viviana Lora; Dario Graceffa; Lorenzo Nosotti
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

9.  Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.

Authors:  Inge M G J Bronckers; Marieke M B Seyger; Dennis P West; Irene Lara-Corrales; Megha Tollefson; Wynnis L Tom; Marcia Hogeling; Leah Belazarian; Claus Zachariae; Emmanuel Mahé; Elaine Siegfried; Sandra Philipp; Zsuzsanna Szalai; Ruth Ann Vleugels; Kristen Holland; Ruth Murphy; Eulalia Baselga; Kelly Cordoro; Jo Lambert; Alex Alexopoulos; Ulrich Mrowietz; Wietske Kievit; Amy S Paller
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

Review 10.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.